About Enhancer
| Enhancer ID: | E_02_0010 |
| Species: | human |
| Position : | chr3:186043535-186045535   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Neuroblastoma |
| Pubmed ID: | 29321660 |
| Enhancer experiment: | ChIP-seq,RT-qPCR |
| Enhancer experiment description: | Altogether, these results define the ERKETV5RET pathway as a critical axis driving neuroblastoma oncogenesis downstream of activated ALK. |
About Target gene
| Target gene : | ETV5,RET(CDHF12,CDHR16,HSCR1,MEN2A,MEN2B,MTC1,PTC-ELE1) |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Altogether, these results define the ERKETV5RET pathway as a critical axis driving neuroblastoma oncogenesis downstream of activated ALK.;Altogether, these results define the ERKETV5RET pathway as a critical axis driving neuroblastoma oncogenesis downstream of activated ALK. |
About TF
| TF name : | -- |
| TF experiment: | ChIP-seq,RT-qPCR |
| TF experiment description: | Altogether, these results define the ERKETV5RET pathway as a critical axis driving neuroblastoma oncogenesis downstream of activated ALK.;Altogether, these results define the ERKETV5RET pathway as a critical axis driving neuroblastoma oncogenesis downstream of activated ALK. |
About Function
| Enhancer function : | Altogether, these results define the ERKETV5RET pathway as a critical axis driving neuroblastoma oncogenesis downstream of activated ALK. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Altogether, these results define the ERKETV5RET pathway as a critical axis driving neuroblastoma oncogenesis downstream of activated ALK. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene